Advanced search
Publication Cover
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
Volume 33, 2007 - Issue 3
Submit an article Journal homepage
155
Views
35
CrossRef citations to date
0
Altmetric
Original

High-Risk Behaviors and Hospitalizations Among Gamma Hydroxybutyrate (GHB) Users

Susan Y. Kim California Poison Control System, Department of Clinical Pharmacy, University of California, San FranciscoUSACorrespondence[email protected]
, Pharm.D.,
Ilene B. Anderson California Poison Control System, Department of Clinical Pharmacy, University of California, San FranciscoUSA
, Pharm.D.,
Jo Ellen Dyer California Poison Control System, Department of Clinical Pharmacy, University of California, San FranciscoUSA
, Pharm.D.,
Judith C. Barker Department of Anthropology, History, Social Medicine, University of California, San Francisco, California, USA
, Ph.D. &
Paul D. Blanc Department of Medicine, University of California, San Francisco, California, USA
, M.D.
Pages 429-438 | Published online: 07 Jul 2009

References

  • Dyer JE, Haller CA. Gamma Hydroxybutyrate and the Comatose Patient. Pulmonary and Critical Care Update Online 2001; 14(lesson 22). Available at http://www.chestnet.org/education/pccu/vol14/lesson21-22.index.html.
  • Anderson IB, Kim SY, Dyer JE, Burkhardt CB, Iknoian JC, Walsh MJ, Blanc PD. Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003. Ann Emerg Med 2006; 47(2):177–183.
  • Knudsen K, Greter J, Verdichio M, Cederquist T. A severe outburst of GHB poisonings (gamma-hydroxybutyrate, gamma-hydroxybutyric acid) on the west cost of Sweden. Mortality numbers ahead of heroin. Clin Tox 2006; 44(5):637–638.
  • Darke S, Hall W, Weatherburn D, Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend 1999; 54(2):155–161.
  • Parrott AC. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology (Berl) 2004; 173(3–4):234–241.
  • Gable RS. Acute toxic effects of club drugs. J Psychoactive Drugs 2004; 36(3):303–313.
  • Albery IP, Strang J, Gossop M, Griffiths P. Illicit drugs and driving: Prevalence, beliefs, and accident involvement among a cohort of current out-of-treatment drug users. Drug Alcohol Depend 2000; 58(1–2):197–204.
  • Movig KL, Mathijssen MP, Nagel PH, van Egmond T, de Gier JJ, Leufkens HG, Egberts AC. Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev 2004; 36(4):631–636.
  • Dyer JE, Anderson IB, Kim SY, Barker JC, Blanc PD. Rational approach to designing a gamma hydroxybutyrate (GHB) structured telephone-administered survey instrument. J Med Tox 2007; 3(1):7–14.
  • Barker JC, Harris S. Dyer, JE. Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study. J Psychoactive Drugs In press.
  • Couper FJ, Logan BK. Addicted to driving under the influence—A GHB/GBL case report. J Analytical Tox 2004; 28(6):512–515.
  • Halkitis PN, Palamar JJ. GHB use among gay and bisexual men. Addict Behav 2006; 31(11):2135–2139.
  • Darke S, Hall W, Carless J. Drug use, injecting practices and sexual behaviour of opioid users in Sydney, Australia. Br J Addict 1990; 85(12):1603–1609.
  • Henderson GL, Harkey MR, Jones AD. Rapid screening of fentanyl (China White) powder samples by solid-phase radioimmunoassay. J Anal Toxicol 1990; 14(3):172–175.
  • National Institute on Drug Abuse. Monitoring the Future Survey: Overview of Key Findings. 2005. Availabe at http://www.monitoringthefuture. Accessed October 30, 2006.
  • Knudsen K, Greter J, Verdicchio M, Cederguist T. GHB, GBL, and butanediol poisonings—A serious problem in Western Sweden. Lakartidningen 2005; 102(45):3294–3299.
  • Park MJ, Paul Mulye T, Adams SH, Brindis CD, Irwin CE Jr. The health status of young adults in the United States. J Adolesc Health 2006; 39(3):305–317.
  • Liechti ME, Kunz I, Greminger P, Speich R, Kupferschmidt H. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug Alcohol Depend 2006; 81(3):323–326.
  • Thai D, Dyer JE, Benowitz NL, Haller CA. Gamma-hydroxybutyrate and ethanol effects and interactions in humans. J Clin Psychopharmacol 2006; 26(5):524–529.
  • Bosman IJ, Lusthof KJ. Forensic cases involving the use of GHB in The Netherlands. Forensic Sci. Int 2003; 133:17–21.
  • Dyer JE, Roth B, Hyma BA. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med 2001; 37(2):147–153.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.